Author
Listed:
- Wen-Song Zhang
(China Pharmaceutical University)
- An Pan
(China Pharmaceutical University)
- Xu Zhang
(China Pharmaceutical University)
- Ang Ying
(China Pharmaceutical University)
- Gaoxiang Ma
(China Pharmaceutical University
China Pharmaceutical University)
- Bao-Lin Liu
(China Pharmaceutical University)
- Lian-Wen Qi
(China Pharmaceutical University
China Pharmaceutical University)
- Qun Liu
(China Pharmaceutical University)
- Ping Li
(China Pharmaceutical University)
Abstract
Glucagon promotes hepatic gluconeogenesis and maintains whole-body glucose levels during fasting. The regulatory factors that are involved in fasting glucagon response are not well understood. Here we report a role of p52, a key activator of the noncanonical nuclear factor-kappaB signaling, in hepatic glucagon response. We show that p52 is activated in livers of HFD-fed and glucagon-challenged mice. Knockdown of p52 lowers glucagon-stimulated hyperglycemia, while p52 overexpression augments glucagon response. Mechanistically, p52 binds to phosphodiesterase 4B promoter to inhibit its transcription and promotes cAMP accumulation, thus augmenting the glucagon response through cAMP/PKA signaling. The anti-diabetic drug metformin and ginsenoside Rb1 lower blood glucose at least in part by inhibiting p52 activation. Our findings reveal that p52 mediates glucagon-triggered hepatic gluconeogenesis and suggests that pharmacological intervention to prevent p52 processing is a potential therapeutic strategy for diabetes.
Suggested Citation
Wen-Song Zhang & An Pan & Xu Zhang & Ang Ying & Gaoxiang Ma & Bao-Lin Liu & Lian-Wen Qi & Qun Liu & Ping Li, 2019.
"Inactivation of NF-κB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction,"
Nature Communications, Nature, vol. 10(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12351-x
DOI: 10.1038/s41467-019-12351-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12351-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.